< Back to latest news & events

Event

Webinar: Patent eligibility of AI-related pharmaceutical inventions and practical tips for its patent obtainment in Japan

November 2021

Event date: 1st December 2021

Join our webinar on 1st December, where speakers from Shiga, one of the leading IP firms in Japan, will present on ‘Patent eligibility of AI-related pharmaceutical inventions and practical tips for its patent obtainment in Japan’.

About the webinar

Digital transformation has been reshaping the pharmaceutical industry. Today, AI has helped explore novel uses of existing drugs, develop new drugs, and accelerate R&D activity in the industry.

In Japan, patent eligibility of AI-related inventions is less strict than that in EP practice. When AI has been applied to pharmaceuticals, issues on inventive step, support requirements, and enable requirements often arise as points to be overcome.

Our speakers will explain patent eligibility on combinations of AI and pharmaceutical inventions, suggesting some practical points of the JPO Examination Guidelines. They will then give listeners insight into some case examples of AI-related pharmaceutical patents in Japan.

Speakers

Dr. Masato Iida, Shiga

Fumio Takahashi, Shiga

Date

1st December, 2021

Time

9:00am (UK)

6:00pm (JST)

Latest updates

Our new 'Fashionably IP' Podcast is now live

We are delighted to launch our new Fashionably IP Podcast were we will be looking at important hot topics in the world of fashion and intellectual property. In the podcast, …

Read article

Prominence given to the preservation of the status quo

The Court of Appeal has stayed an interim injunction to allow Mylan’s generic to remain on the market in a bid to preserve the status quo, despite recognising that damages …

Read article

Managing Intellectual Property IP Stars 2022

After months of research, Managing IP has published the IP Stars list for 2022. HGF is delighted to have 16 attorneys from England, Scotland, Ireland, Netherlands and Germany recognised and …

Read article